Alzheimer’s Drug Targets People With Mild Cognitive Impairment. What Does That Mean?
(By Judith Graham for Kaiser Health News) The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining
Read More(By Judith Graham for Kaiser Health News) The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining
Read More(By Kavitha Cardoza for NPR) Many Americans hope to spend their old age at home, rather than moving into a
Read MoreThe U.S. Department of Health and Human Services has projected more than one in four retirees will need long-term care
Read More(By Erica Carbajal for Becker’s Hospital Review) The COVID-19 pandemic sparked life expectancy losses not seen since World War II,
Read More(By Cynthia Cox, Karen Pollitz, and Giorlando Ramirez for Kaiser Family Foundation published September 24, 2021) The American Rescue Plan
Read MoreAccording to the experts at Fidelity, you will need about $300,000 to cover your health care costs, that’s even with
Read MoreOn Friday, Centers for Disease Control and Prevention Director Rochelle Walensky said people whose jobs put them at risk of
Read More(By Matthew Herper for STAT) Gilead’s Covid-19 drug remdesivir appeared to reduce hospitalizations by 87% in high-risk patients diagnosed early
Read More(By Maia Anderson for Becker’s Hospital Review) The HHS Health Resources & Services Administration sent letters to six drugmakers Sept.
Read More(By Daniel R. George and Peter Whitehouse for STAT) Billions of dollars have been spent in pursuit of a pharmaceutical
Read More